# NEUBASE THERAPEUTICS INC (NBSE) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 64132K102
Page URL: https://superinvestorclub.com/stock/NBSE
Last updated: 2026-08-29T13:49:06.029Z

## Summary

As of the most recent 13F filing period, NEUBASE THERAPEUTICS INC (NBSE) is held by 0 tracked superinvestors with an aggregate position value of $0 representing 0 shares.

## Top institutional holders (0)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|

## Ownership history (quarter-over-quarter)

- 2021-09-30: 1 holders, $9.8M aggregate, 02727027 shares
- 2021-12-31: 1 holders, $7.7M aggregate, 02727027 shares
- 2022-03-31: 1 holders, $5.1M aggregate, 02727027 shares
- 2022-06-30: 1 holders, $2.9M aggregate, 02727027 shares
- 2022-09-30: 1 holders, $1.1M aggregate, 02727027 shares
- 2022-12-31: 1 holders, $518,681 aggregate, 02727027 shares
- 2023-03-31: 1 holders, $504,500 aggregate, 02727027 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "NEUBASE THERAPEUTICS INC (NBSE) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/NBSE), aggregating SEC 13F, Form 4, and congressional disclosures."